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Abstract
Hepatitis C virus (HCV) is classified into seven genotypes based on genetic diversity, and most 
genotypes have been found in Africa. Infections with HCV genotype 2 (HCV2) are most prevalent 
in West Africa and it was suggested that HCV2 originated in West Africa. To better understand 
the evolutionary epidemiology of HCV2 in Africa, we examined new NS5B sequences of HCV2 
strains obtained from Côte d’Ivoire, Ghana and Nigeria sequenced at the Centers for Disease 
Control and Prevention with those available from West, North and Central Africa. Bayesian 
phylogeographic analysis using a discrete trait model showed that Ghana was the most likely 
geographical region for the origin of HCV2. Spread of HCV2 from Ghana did not appear to be 
through diffusion to adjacent countries along the coast. Rather, it was transmitted from Ghana to 
many distant countries in Africa, suggesting that certain routes of geographical dissemination were 
historically more efficient than mere proximity and that the HCV2 epidemic history in West 
Africa is extremely complex.
INTRODUCTION
Infection with hepatitis C virus (HCV) is a serious global public health problem. Chronic 
HCV infection may progress to cirrhosis, leading to severe complications including 
hepatocellular carcinoma and end-stage liver failure (EASL, 1999; Itskowitz, 2007). It is 
estimated that ~170 million individuals or ~2.8% of the world’s population are chronically 
infected and 3–4 million new cases of hepatitis C occur every year (WHO, 2012). Countries 
in Africa and Asia have the highest infection rates with estimated regional prevalences of 
1.6–4.5% (Hanafiah et al., 2013).
HCV is a small, positive-sense, ssRNA virus in the genus Hepacivirus, family Flaviviridae 
(Choo et al., 1991; Lindenbach & Rice, 2005). The HCV genome is ~9600 nt and encodes a 
Correspondence Michael A. Purdy MPurdy@cdc.gov. 
One supplementary figure and one table are available with the online Supplementary Material.
HHS Public Access
Author manuscript
J Gen Virol. Author manuscript; available in PMC 2016 August 01.
Published in final edited form as:













single polyprotein with the following gene order: 5′-core–envelope (E1–E2)–non-structural 
proteins [NS1(p7)–NS2–NS3–NS4A–NS4B–NS5A–NS5B]-3′. The HCV genome is 
extensively heterogeneous. Currently, HCV is classified into seven genotypes that share 
between 65 and 70% nucleotide identity, each of which is further divided into subtypes and 
displays different global geographical distributions (Nakano et al., 2012; Smith et al., 2014).
Candotti et al. (2003) analysed the viral diversity of HCV genotype 2 (HCV2) sequences 
from Ghana. These sequences were found to have greater diversity than was found in other 
regions around the world, suggesting that HCV2 originated in West Africa. Furthermore, 
HCV2 sequences from Cameroon were found to be less diverse, suggesting an introduction 
of HCV2 from West Africa (Pasquier et al., 2005). This finding was confirmed through the 
use of Bayesian analysis that showed HCV2 sequences in Cameroon had diverged more 
recently from their most recent common ancestor (MRCA) than had sequences from West 
Africa. Additionally, the Cameroon HCV2 sequences were inferred to have undergone 
exponential expansion between 1920 and 1960, suggesting rapid epidemic growth due to 
unsafe medical practices, whilst HCV2 spread relatively slowly in West Africa (Njouom et 
al., 2007; Pouillot et al., 2008). Phylogenetic analysis using an expanded set of sequences 
confirmed the eastward diffusion of HCV2 that took place over several centuries in West 
Africa. This spread appeared to be between adjacent countries, and sequences from Guinea-
Bissau were most phylogenetically basal and genetically diverse, suggesting that HCV2 may 
have originated in this region of West Africa (Markov et al., 2009).
Whilst these earlier studies increased our understanding of the evolutionary history of 
HCV2, they may have been limited by undersampling from other African countries where 
HCV2 is prevalent. Here, we report the genetic analysis of HCV2 sequences from several 
African countries, including those recently obtained from Côte d’Ivoire, Ghana and Nigeria 
in West Africa, showing that Ghana is the most likely origin for HCV2.
RESULTS
Genetic diversity
To analyse the evolution of HCV2 in West Africa, sequences from Côte d’Ivoire, Ghana and 
Nigeria that were sequenced at the Centers for Disease Control and Prevention were added 
to West African sequences that were analysed previously (Candotti et al., 2003; Markov et 
al., 2009; Pasquier et al., 2005; Pouillot et al., 2008) (Table S1, available in the online 
Supplementary Material). As slightly different regions in the NS5B gene were sequenced in 
these studies, it was decided to create two sequence alignments for analysis. The first, trim1, 
contained the maximum number of sequences (n=300) compatible in length with the dataset 
from Markov et al. (2009), whilst the second, trim2 (n=340) included 40 additional 
sequences from Guinea-Bissau, but the length of the trim1 sequences were shortened 12 nt 
to align with the Guinea-Bissau sequences. As the results from trim1 were in agreement with 
those from trim2, only the trim2 results are presented in this paper.
Analysis of trim2 sequence diversity among HCV2 sequences showed that sequences from 
Ghana were the most diverse. Sequences from Burkina Faso, Cameroon, Guinea-Bissau, 
Morocco, Nigeria and Tunisia had a mean sequence diversity of 0.26 (SD 0.03), whilst those 
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from Ghana had a diversity of 0.45. In fact, the diversity seen in Ghana was greater than 
seen among all other countries combined (0.32).
Molecular clock
In order to determine the best molecular clock for this analysis, the strict, log-normal and 
exponential clocks were tested using fixed and estimated substitution rates with an initial 
rate of 5×10−4 substitutions per site per year. These models were compared against each 
other using Bayes factor analysis calculated using marginal-likelihood analysis. Among 
either the fixed rate models or the estimated rate models, the exponential clock had the 
highest Bayes factor; each exceeding a value of 3 when compared with the other clocks. The 
fixed rate, exponential clock model was better than the estimated rate, exponential clock 
model with a minimum Bayes factor value of 7 (Table 1) (Kass & Raftery, 1995). A fixed 
rate of 5×10−4 substitutions per site per year was chosen to make these analyses compatible 
with those of Markov et al. (2009).
Phylogeography
A discrete trait model was used to recreate a phylogeographic tree in a Bayesian framework. 
Initial runs showed that the posterior probabilities for some branches near the root of the tree 
were <0.7. To determine the variation in the position of these nodes, each model was 
replicated 10 times. In each run, Ghana was at the root of each tree with a posterior 
probability of 1.0 and a location probability of 0.997 (SD 6.4×10−4) for the 300 trim1 
sequence alignment and 0.97 (SD 6.7×10−3) (Fig. 1) for the 340 trim2 sequence alignment. 
Some clades with posterior probabilities >0.7 appeared to be country specific: Guinea-
Bissau, Cameroon, Madagascar, Morocco and Tunisia. These clades appeared in each tree 
and had posterior probabilities >0.7, except for the Guinea-Bissau clade; however, in spite 
of having a posterior probability as low as 0.24 on one tree, the Guinea-Bissau sequences 
consistently formed a clade in all replicate trees. The low posterior probability for the 
Guinea-Bissau clade appeared to be due to the inclusion/exclusion of a few sequences from 
Burkina Faso, Côte d’Ivoire, Ghana and Madagascar disrupting a fixed branching structure 
within the Guinea-Bissau clade. Although these clades appeared in all replicate trees, 
additional HCV2 sequences from these countries could be found variously distributed in the 
replicate trees. For example, sequences from Tunisia formed two to four additional clades in 
the replicates, but these clades were not found among all replicates and did not always have 
high posterior probabilities (Fig. 1). These alternative clades suggested multiple 
introductions of HCV2 to these countries, but the number of introductions and the timing of 
these introductions could not be determined from our analyses.
The program SPREAD was used to analyse the Bayesian phylogeographic reconstructions 
by incorporating spatial diffusion. This analysis indicated that Ghana was positioned at the 
centre of a web of links to other countries within Africa (Fig. 2). Most of the links between 
African countries included Ghana (n=10). The value n is the number of independent 
linkages calculated between a country, Ghana in this case, and other countries in West 
Central and North Africa. The next most connected countries were Burkina Faso (n=3) and 
Cameroon (n=3). The highest Bayes factors from this analysis were seen in linkages 
between Ghana and Burkina Faso, Côte d’Ivoire, Guinea-Bissau, Nigeria and Tunisia (Table 
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2). This finding was consistent with the basal location of the sequences from Ghana, and 
indicated a direct linkage between Ghana and all other countries with sequences in this 
study, except Algeria and Guinea. Furthermore, this was especially true for Morocco, 
Madagascar and Tunisia. However, a diffusion of HCV2 through neighbouring countries 
from Ghana to North Africa may have been missed due to lack of sequences from Mali, 
Mauritania and Niger.
Outgroup sequences
A maximum-likelihood tree published as Fig. 1 in Markov et al. (2009) contained HCV2 
sequences that formed an outgroup to the main body of HCV2 sequences, including 
GenBank accession numbers AY236381 (Ghana), DQ345617 (Madagascar), FJ791094 
(Central African Republic), GQ153866 (Guinea-Bissau) and GQ153902 (Guinea-Bissau). In 
the trees recreated here, none of these sequences appeared to form an outgroup (Fig. S1). 
Additionally, the two Guinea-Bissau sequences (GenBank accession numbers GQ153866 
and GQ153902) clustered within the Guinea-Bissau clade in the trees inferred from our 
analyses.
Time to MRCA (TMRCA)
The inferred mean TMRCA to the root of the trees from the discrete location trait model 
runs was 602 years ago (SD 6.5 years) with a range of 514 (SD 6.5) to 695 years ago (SD 
6.6 years) for the trim1 sequence alignment, and 618 years ago (SD 6.4 years) with a range 
of 540 (SD 6.3) to 698 years ago (SD 9.7 years) for the trim2 sequence alignment. These 
estimates were similar to those from other studies (Markov et al., 2009; Pasquier et al., 
2005; Pouillot et al., 2008). The discrete trait model was used to compare the results of this 
study with earlier studies. The reason for this was because TMRCA estimates from the 
discrete trait model and a model using the constant growth tree prior should yield similar 
results, but this study found that the trim2 mean TMRCA estimates with the constant growth 
prior were 7045 years ago [1693–17413 years ago, 95% highest posterior density (HPD)] 
and 2913 years ago (1385–5170 years ago, 95% HPD) using a fixed substitution rate of 
5×10−4 substitutions per site per year for the uncorrelated exponential and log-normal 
molecular clocks, respectively. As a result of the disparity between the discrete trait and 
constant growth prior models, the time estimates in this paper are not considered to be 
accurate, but are used as a relative measure of events. TMRCA estimates for the country 
clades marked in Fig. 1 can be found in Table 3.
These results show that HCV2 had most likely spread throughout West, North and Central 
Africa along a temporal gradient with transmission to countries closer to Ghana at earlier 
times than countries further away from Ghana. Nigeria appeared to be an exception, but not 
all Nigerian HCV2 sequences were contained in a single clade, suggesting more than one 
introduction there. Sequences not belonging to this clade had TMRCAs back to Ghana in the 
range of 500–250 years ago, suggesting the potential for earlier introductions of HCV2 into 
Nigeria. More extensive sampling of HCV2 sequences from Nigeria will be required to 
obtain better estimates of these events.
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Many studies investigating the evolution and molecular epidemiology of HCV2 over the last 
decade suggest that HCV2 originated in West Africa. A region encompassing Guinea and 
the Gambia was assumed to be the most probable site for the origin of HCV2 as sequences 
from this region were the most phylogenetically basal and more genetically diverse than 
sequences from other regions in West, North and Central Africa (Markov et al., 2009). 
Recent research indicated that HCV2 was more likely to have spread between adjacent 
countries through diffusion from west to east over several centuries (Markov et al., 2009; 
Pouillot et al., 2008). To further explore the diversity and evolutionary history of HCV2, we 
re-examined HCV2 sequences collected from West, North and Central Africa, including 92 
new sequences from Côte d’Ivoire, Ghana and Nigeria.
An analysis of sequence diversity shows that the sequences from Ghana were more 
genetically diverse (0.45) than sequences from any other country or all other countries 
combined (0.32). Discrete trait Bayesian analysis using the geographical location of the 
collected sequences demonstrated that Ghana was phylogenetically basal (Fig. 1). The 
location probability for Ghana at the root of the inferred trees was 0.97–0.997. Bayesian 
phylogenetic reconstruction of evolutionary dynamics to examine pairwise diffusion 
linkages between the countries studied showed that Ghana was most phylogenetically basal 
and had the most pairwise linkages to other countries, except Algeria and Guinea, which 
were linked to Morocco and Burkina Faso, respectively (Figs. 1 and 2).
As was observed earlier, the frequency of detection of HCV2 versus other HCV genotypes 
varies among countries in West Africa. However, the HCV2 frequency does not decline 
steadily from the most western to central coastal regions of the subcontinent. Instead, its 
frequency fluctuates. Among all HCV strains from West Africa, HCV2 was found in 85% of 
cases in Guinea, Guinea-Bissau (Markov et al., 2009) and Ghana (Layden et al., 2015), and 
only in 33, 25 and 15% (Forbi et al., 2012, 2014; Markov et al., 2009) of cases in Côte 
d’Ivoire, Cameron and Nigeria, respectively. Thus, the countries of Guinea and Ghana with 
the highest HCV2 frequency are separated by Côte d’Ivoire with a low HCV2 frequency, 
which is inconsistent with the west-to-east gradient of HCV2 frequency proposed earlier. 
Although diffusion of HCV2 between neighbouring countries is possible, irregular 
geographical distribution of this genotype contradicts its gradual dissemination from West to 
Central African countries along the coast of the subcontinent. However, the introduction of 
other HCV genotypes, e.g. genotype 1 in Côte d’Ivoire (Forbi et al., 2014) and Nigeria 
(Forbi et al., 2012), might influence HCV2 prevalence in these countries by displacing 
HCV2 as the dominant genotype.
Combined, the aforementioned observations suggest direct introduction of HCV2 from 
Ghana to most other countries in this study rather than diffusion through chains of linkages 
such as Ghana–Côte d’Ivoire–Guinea–Guinea-Bissau. The inferred TMRCAs suggest a 
temporal diffusion of HCV2 out of Ghana (Table 3), although this sampling of country-
specific clades is not conclusive as country-specific sequences are not monophyletic (Fig. 
1). Instead, the tree topologies suggest multiple introduction events of HCV2 to countries 
such as Nigeria and Tunisia. The strength of these introduction events are difficult to 
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estimate because of the low posterior probabilities associated with these sequences. More 
extensive sampling for HCV2 in these countries may allow better estimates to be made in 
the future.
The data obtained here indicate that strain sampling is very important for identification of 
the HCV2 geographical origin. Sampling of sequences in West Africa has been inconsistent, 
as noted here. Some countries are under-represented and other countries are not sampled. 
This could influence our study. Originally, Candotti et al. (2003) suggested HCV2 
originated in Ghana with limited sampling. Markov et al. (2009) were able to expand the 
West African HCV sequence set and their results indicated that Guinea-Bissau might be the 
origin for HCV2. With the further expansion of West African HCV2 sequences presented 
here, it appears that Ghana is once again the location of the origin. With additional sampling 
the origin of HCV2 should be better estimated. Additional sequences allowed for resolving 
phylogenetic relationships of a small set of sequences that appeared to form an outgroup 
(Fig. 1 in Markov et al., 2009) by showing that these sequences were not an actual outgroup 
(Fig. S1). These observations suggest that the HCV2 epidemic history in West Africa is 
extremely complex and can be accurately elucidated using only a very substantial sample of 
HCV2 sequences from all countries in this geographical region. HCV2 did not radiate from 
Ghana evenly to all countries in West Africa, with distant countries such as Guinea and 
Guinea-Bissau having experienced a significant influx, whilst neighbouring countries such 
as Côte d’Ivoire and Nigeria have a low frequency of HCV2. Such an erratic spatial 
distribution suggests that certain routes of geographical dissemination may have been more 
efficient than mere proximity.
Unlike earlier research, the linkages between Ghana and countries in North and Central 
Africa suggest a direct linkage between these countries and Ghana rather than diffusion 
between adjacent countries. It is conceivable that dissemination of HCV2 along trade routes, 
such as those dominating sub-Saharan Africa from the eighth to the sixteenth century, could 
have contributed to the modern patterns of HCV2 in Africa. Nonetheless, sampling of HCV2 
sequences from unrepresented countries like Mali, Mauritania and Niger may help in 
understanding the contemporary patterns of HCV2 distribution in the region. Considering 
that northern Ghana is in geographical proximity to the major ancient trading centres at the 
southern edge of the Sahara, such as Timbuktu, Jenne and Gao, but has never served as a 
major trading centre itself, it is conceivable that HCV2 was continuously dispersed from 
Ghana through these trading centres to other geographical regions over many centuries, with 
the rate of dispersion having been affected by the extent of human travel related to the trade, 
which may potentially explain variation in the introduction of HCV2 to different African 
regions. In this respect, it is intriguing that a few HCV2 sequences sampled from Burkina 
Faso are scattered across HCV2 clusters (Fig. 1), suggesting that this country either is a part 
of the geographical origin or experienced numerous introductions of HCV2 from Ghana. A 
massive introduction of HCV2 to the most western countries of the subcontinent, such as 
Guinea-Bissau, may reflect a certain ease of communication through the Niger River along 
the ancient trading routes.
In conclusion, our results suggest that Ghana was the geographical place of origin for HCV2 
in West Africa. A more extensive sampling of additional HCV2 sequences from 
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unrepresented and under-represented countries in West, North and Central Africa will help 




Cote d’Ivoire—In total, 608 plasma samples were obtained in 1995 from pregnant women 
in various hospitals throughout Côte d’Ivoire as part of human immunodeficiency virus 
surveillance studies. This resulted in the isolation of six HCV2 sequences with GenBank 
accession numbers KC012573, KC012577, KC012578, KC012585, KC012587 and 
KC012588. Additional details can be found in Forbi et al. (2014).
Ghana—In total, 363 blood samples from a population of recalled blood donors from the 
Komfo Anokye Teaching Hospital (KATH) blood bank, Kumasi, Ghana, were collected in 
2012–2013. The HCV2 sequences from that study have the GenBank accession numbers 
KM213527–KM213591. Additional details can be found in Layden et al. (2015).
Nigeria—In total, 519 serum specimens were randomly obtained from asymptomatic 
indigenes from two rural communities in Keffi, Nigeria in 2007. Nine HCV2 sequences 
were isolated from this study with GenBank accession numbers JQ679028–JQ679036. 
Additional details can be found in Forbi et al. (2012).
Nucleic acid extraction and DNA sequencing—Total nucleic acid was extracted 
from all samples using an automated MagNA Pure LC robot and a MagNA Pure LC Total 
Nucleic Acid Isolation kit (Roche), and eluted with 50 μl elution buffer according to the 
manufacturer’s instructions. cDNA was generated using a high-temperature capability 
SuperScript VILO cDNA Synthesis kit (Invitrogen) on an ABI PRISM 9700 PCR system. 
The PCR conditions following reverse transcriptase were: 25°C for 10 min, 42°C for 90 min 
and 85°C for 5 min.
Amplification of the NS5B gene region was done as described previously (Forbi et al., 
2012). Nested NS5B amplicons derived from the PCR amplification were purified (PCR 
purification kit; Qiagen) and sequenced with their respective nested primers using a BigDye 
v3.1 chemistry sequencing kit (Applied Biosystems) with an automated sequencer (ABI 
3130xl; Applied Biosystems) as described previously (Forbi et al., 2012).
Sequence diversity—Sequence diversity was calculated from sequence similarity using 
BioEdit (version 7.1.3.0) (Hall, 1999). Sequence diversity was calculated as 1 minus the 
fraction of sequence identity between sequences.
Sample analysis—A sequence database was created with all the HCV2 sequences from 
these studies combined with additional West African sequences, with dates of collection, 
downloaded from Gen-Bank. Sequences were aligned visually and the termini were trimmed 
in BioEdit (version 7.1.3.0) (Hall, 1999) to remove gaps resulting in an alignment of 246 nt 
containing 340 sequences (Table S1). The sequences aligned between positions 8371 to 
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8616 using GenBank accession number NC_009823 as reference. Two sequence alignments 
were created from this alignment. In the first alignment, all sequences <246 nt were 
removed, resulting in an alignment containing 300 sequences (trim1). In the second 
alignment, 12 bases were trimmed from the 5′ end of the alignment resulting in an alignment 
of 340 sequences covering positions 8383–8616 (234 nt). The first alignment maximized the 
length of the sequences, whilst the second alignment maximized the number of sequences 
from Guinea-Bissau, which were under-represented in the first dataset (trim2).
Coalescent analysis—BEAST (version 1.8.1) (Drummond et al., 2012) was used to 
estimate the TMRCA and reconstruct phylogeographic trees using a discrete trait model. 
The HKY substitution model was used with four Γ rate categories and invariant sites. An 
initial clock rate of 5.0×10−4 substitutions per site per year as determined by Pybus et al. 
(2001) was used so these analyses could be compared with the results of Markov et al. 
(2009). For TMRCA analyses, a coalescent constant size prior was used for the analysis. 
Clock rates were either fixed or estimated using strict, log-normal or exponential clocks. A 
chain length of 1×108 was used, and parameters and trees were logged every 5000 iterations. 
Convergence was inspected using the trace option in Tracer (version 1.6). A 10% burn-in 
was applied to the log and tree files. Bayes factors were calculated using marginal-
likelihood analysis in Tracer (version 1.5) with 1000 bootstrap replicates (Kass & Raftery, 
1995).
Phylogeography—A phylogenetic tree with discrete geographical location traits (http://
beast-classic.googlecode.com/files/ARv2.0.1.pdf) associated with the tips of the tree used 
the substitution model listed above for the nucleotide sequences and the symmetrical 
substitution model with social network inferred with Bayesian stochastic search variable 
selection was used for the location trait. The clock for the nucleotide sequences used the rate 
and clocks listed above, and the location trait rate was estimated used a strict clock with the 
default rate, the continuous time Markov chain rate reference prior distribution and the 
GMRF Bayesian Skyride tree prior (Minin et al., 2008). The analysis was run 10 times to 
determine the variation in results. Parameter estimates are reported as mean±SD. The tree in 
Fig. 1 was chosen at random.
Pairwise diffusion—The discrete Bayes factors for each pairwise location indicator 
between locations were calculated using SPREAD (version 1.0.6) with a Bayes factor cut-
off of 3.0 (Bielejec et al., 2011).
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Discrete location trait Bayesian tree for the trim2 sequence alignment. The legend in the 
upper left corner shows the colour coding for the branches in the tree. The numbers at the 
nodes of the tree are posterior probabilities. Posterior probabilities <0.7 were excluded. The 
timescale is specific for this tree. A, Guinea-Bissau clade; B, Cameroon clade; C, 
Madagascar clade; D, Morocco clade; E, Tunisia clade. Two-letter country codes: AL, 
Algeria; BF, Burkina Faso; BN, Benin; CA, Central African Republic; CI, Côte d’Ivoire; 
CM, Cameroon; GB, Guinea-Bissau; GH, Ghana; GU, Guinea; MD, Madagascar; MO, 
Morocco; NG, Nigeria; TN, Tunisia.
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Spatial diffusion of HCV2. The lines show calculated spatial diffusion between pairs of 
countries in West Africa. Thicker lines indicate the higher Bayes factor support for a linkage 
pair (see also Table 2). The dashed line indicates the linkage between Burkina Faso and 
Benin was only seen in two of the 10 replicate runs. Two-letter country codes are the same 
as in Fig. 1.
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Table 3
TMRCA and lower/upper 95 % HPD data (years ago) for select sequence clades
Data are listed as mean (SD) of 10 replicate runs. Two-letter country codes are the same as in Fig. 1.
TMRCA Lower 95 % HPD Upper 95 % HPD
GB 561 (13.5) 481 (9.6) 641 (8.0)
CM 519 (4.7) 431 (4.5) 608 (8.5)
MO 390 (7.1) 291 (6.8) 491 (9.4)
TN 362 (16.4) 289 (10.3) 434 (37.7)
MD 320 (3.6) 210 (4.5) 435 (5.6)
NG 262 (19.6) 160 (15.1) 371 (27.2)
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